Clinical and biochemical differences between patients with aspirin-induced asthma/rhinitis Source: Annual Congress 2005 - PG18 - Inter-relationships between upper and lower airway diseases Year: 2005
15-LOXb is the enzymatic source of aspirin induced 15-HETE generation in aspirin-sensitive patients Source: Eur Respir J 2005; 26: Suppl. 49, 342s Year: 2005
The pathology of the platelet‘s melatonin production in aspirin-induced asthma Source: Eur Respir J 2007; 30: Suppl. 51, 370s Year: 2007
Oral corticosteroid treatment reduces serum chitotriosidase activity in patients with COPD Source: Annual Congress 2010 - COPD: treatment and monitoring Year: 2010
Effect of systemic steroid treatment on nasal nitric oxide level in patients with chronic rhinosinusitis. A pilot study Source: Eur Respir J 2001; 18: Suppl. 33, 338s Year: 2001
The effectiveness of N-acetylcysteine in the suppression of pro-inflammatory cytokines in patients with COPD Source: Virtual Congress 2021 – New insights into the airway immunology of lung disease Year: 2021
Anti-inflammatory effects of add-on atorvastatin therapy during the treatment of COPD patients Source: Annual Congress 2012 - Trials in COPD: novel treatments and insights Year: 2012
Effect of oral N-acetylcysteine treatment on systemic inflammatory status in COPD patients Source: Eur Respir J 2005; 26: Suppl. 49, 716s Year: 2005
Enhanced anti-inflammatory effects by combine inhaled nitric oxide and steroids in SARS patients and in a porcine sepsis model Source: Eur Respir J 2004; 24: Suppl. 48, 91s Year: 2004
Effect of growth hormone therapy on nitric oxide formation in cystic fibrosis patients Source: Eur Respir J 2008; 31: 815-821 Year: 2008
Decreased levels of myeloperoxidase in induced sputum of COPD patients after oral glucocorticoids treatment Source: Eur Respir J 2002; 20: Suppl. 38, 404s Year: 2002
Increase in systemic IL-5 is associated with mepolizumab treatment failure in patients with severe asthma Source: International Congress 2018 – Role of IgE and interleukin (IL)-5 in Th2-cell signatures Year: 2018
Aspirin-induced asthma as the pathology of the platelet‘s melatonin production Source: Eur Respir J 2006; 28: Suppl. 50, 236s Year: 2006
Effects of treatment with N-acetylcysteine or inhaled corticosteroids on inflammatory mediators in COPD-patients Source: Eur Respir J 2003; 22: Suppl. 45, 5s Year: 2003
The effects of parenteral prostacyclin therapy as add-on treatment to oral compounds in Eisenmenger syndrome Source: Eur Respir J, 54 (5) 1901401; 10.1183/13993003.01401-2019 Year: 2019
Azithromycin in the anti-inflammatory treatment of children with asthma Source: Eur Respir J 2004; 24: Suppl. 48, 167s Year: 2004
Pentoxifylline and reduced doses of steroids combination in pulmonary sarcoidosis Source: Eur Respir J 2007; 30: Suppl. 51, 110s Year: 2007
Efficacy of low dose theophylline in patient with bronchial asthma - anti-inflammatory effect Source: Eur Respir J 2003; 22: Suppl. 45, 102s Year: 2003
Effect of systemic steroid treatment on serum leptin levels in patients with COPD exacerbation Source: Eur Respir J 2005; 26: Suppl. 49, 284s Year: 2005
Aspirin significantly decreases urinary leukotriene E4 concentration in aspirin-tolerant asthma patients who show hyperleukotrienuria in stable condition Source: Annual Congress 2007 - New mechanisms in the pathogenesis of asthma and allergy Year: 2007